Santhera Updates on Ongoing NDA Submission for Vamorolone in Duchenne
Today Santhera shared an update on the timeline for the submission of their New Drug Application (NDA) for Vamorolone, an investigational dissociative steroid for individuals with Duchenne. Santhera expects to complete the submission of their…Learn More